Fibroblast growth factors in schizophrenia.

Abstract

A large association study by O'Donovan et al recently suggested that genetic variation in fibroblast growth factor receptor (FGFR) 2 increases the risk for developing schizophrenia. Fibroblast growth factors (FGFs) are part of the family of glial growth factors; they control the growth and patterning of specific brain structures and regulate the maintenance and repair of neuronal tissues. In addition, a direct interaction was recently found between FGFRs and adenosine A(2A) receptors, leading to corticostriatal plasticity and antagonizing the signaling pathway of dopamine D(2) receptors. These findings make FGFs plausible candidate genes for schizophrenia. Here, we review the role of FGFs in schizophrenia and combine evidence from studies on variations in FGF genes, RNA expression, protein levels, and FGF administration, as well as the effects of medication and environmental risk factors for schizophrenia. These data suggest that changes in the FGF system contribute to schizophrenia and possibly to a wider range of psychiatric disorders. The role of FGFs in schizophrenia and related disorders needs to be studied in more detail.

• Authors: Afke F Terwisscha van Scheltinga, Steven C Bakker, René S Kahn
• Journal: Schizophrenia bulletin (Schizophr Bull) Vol. 36 Issue 6 Pg. 1157-66 (Nov 2010) ISSN: 1745-1701 [Electronic] United States
• PMID: 19429845 (Publication Type: Journal Article, Review)

Chemical References

• RNA, Messenger
• Receptors, Fibroblast Growth Factor
• Fibroblast Growth Factors
• Receptor, Fibroblast Growth Factor, Type 2

Topics

• Animals
• Brain (drug effects, metabolism)
• Fibroblast Growth Factors (administration & dosage)
• Genetic Predisposition to Disease
• Humans
• RNA, Messenger
• Receptor, Fibroblast Growth Factor, Type 2 (genetics, metabolism)
• Receptors, Fibroblast Growth Factor (genetics)
• Schizophrenia (drug therapy, genetics, metabolism)